Wednesday, April 02, 2025 11:41:53 AM
Pfizer pays a dividend of 6.96% annual yield. So even when it goes down a little investors still make money.
You also said it had nothing in the future brewing.
Wrong, wrong, wrong.
They are prepped to do some cancer fighting.
Talk about cash for the long haul if even a few of the 8 drugs in the works does well.
https://www.fiercepharma.com/pharma/pfizer-fleshes-out-oncology-strategy-targeting-8-blockbuster-cancer-drugs-2030
https://www.cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
Shares are at a low now, plus its a healthy company with a long future that pays great dividends.
Thats the type of investment smart investors are looking for and is the reasons those with millions of shares are interested in a buyout for shares if its a company like Pfizer.
Last comment about us taking our profit and just buying shares. That is a dumb suggestion, dumb, dumb, dumb. To invest hundreds of thousands to a few million dollars of cash into PFE one would certainly affect share price. A buyout for shares is an instantaneous transfer at a fixed price. Definitely saves money and time (and my time has a good bit of value to me).
You also said it had nothing in the future brewing.
Wrong, wrong, wrong.
They are prepped to do some cancer fighting.
Talk about cash for the long haul if even a few of the 8 drugs in the works does well.
https://www.fiercepharma.com/pharma/pfizer-fleshes-out-oncology-strategy-targeting-8-blockbuster-cancer-drugs-2030
https://www.cnbc.com/2024/03/10/pfizer-is-betting-big-on-cancer-drugs-after-covid-decline.html
Shares are at a low now, plus its a healthy company with a long future that pays great dividends.
Thats the type of investment smart investors are looking for and is the reasons those with millions of shares are interested in a buyout for shares if its a company like Pfizer.
Last comment about us taking our profit and just buying shares. That is a dumb suggestion, dumb, dumb, dumb. To invest hundreds of thousands to a few million dollars of cash into PFE one would certainly affect share price. A buyout for shares is an instantaneous transfer at a fixed price. Definitely saves money and time (and my time has a good bit of value to me).
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
